Dr. Govindan is the Director of Medical Oncology in the Division of Oncology and Professor of Medicine in the Department of Medicine at Washington University School of Medicine (WUSM) in St. Louis, MO. He received his Medical Degree from the University of Madras in India, and undertook internship and residency training in Internal Medicine at Michael Reese Hospital and Medical Center in Chicago, IL. Dr. Govindan completed his fellowship in Hematology-Oncology at WUSM and joined the faculty in 1998.
Dr. Govindan is interested in studying genomic alterations in lung cancer and translating these findings in the clinic. Dr. Govindan has led several national and international clinical trials in lung cancer. He is the Principal Investigator for the NCI sponsored ALCHEMIST Trial to study the impact of targeted therapy in early stage lung cancer.
Dr. Govindan is the Co-Chair of the lung cancer working group for The Cancer Genome Atlas project funded by the National Cancer Institute (NCI). He is also the Principal Investigator of the NCI sponsored Paul Calabresi K12 Oncology Training Program and the R25 STRENGTH program at WUSM.
- Director of Medical Oncology
Division of Oncology
Professor of Medicine
Department of Medicine
Washington University School of Medicine
St. Louis, MO